Related Experiment Videos
Partial characterization of the embryo-derived platelet-activating factor in mice
Journal of Reproduction and Fertility
|November 1, 1985
Summary
Mouse embryos produce platelet-activating factor (PAF) with properties mirroring PAF-acether. This embryo-derived PAF is sensitive to chlorpromazine and phospholipases, indicating a phospholipid structure similar to PAF-acether.
Area of Science:
- Biochemistry
- Embryology
- Immunology
Background:
- Platelet-activating factor (PAF) plays a role in various biological processes.
- The precise nature and function of PAF produced during embryonic development are not fully understood.
Purpose of the Study:
- To characterize the biochemical and physiological properties of PAF produced by mouse embryos.
- To compare embryo-derived PAF with the known standard, 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphocholine (PAF-acether).
Main Methods:
- Bioassay to determine kinetics and dose-response curves.
- Enzyme inhibition assays using phospholipases and pathway-specific inhibitors (indomethacin, chlorpromazine).
- Challenging extraction and thin-layer chromatography for structural analysis.
Main Results:
- Embryo-derived PAF exhibited similar kinetics and dose-response curves to PAF-acether.
- Activity was unaffected by ADP or cyclo-oxygenase pathway inhibitors but was inhibited by chlorpromazine.
- Phospholipases A2, C, and D inhibited activity, suggesting a phospholipid structure.
- Extraction and chromatography confirmed similarities to PAF-acether.
Conclusions:
- Embryo-derived PAF shares significant chemical, biochemical, and physiological characteristics with PAF-acether.
- These findings suggest a conserved structure and potential role for PAF in embryonic development.